Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


TVM Capital promotes Dr. Keiarasch ‘Kia’ Parssanedjad to Principal


January 24, 2008, Munich, Germany - Dr. Kia Parssanedjad joined the TVM Capital life sciences practice in early 2007 as a senior associate, based in Munich. As a principal, he will be involved in deal origination and the evaluation of new investments, as well as research and support for existing portfolio companies with an emphasis on clinical development stage to commercial stage investments.

“As a member of the deal team on our recent growth capital investment into Riemser Arzneimittel AG he has shown that he is a great addition to our professional team ,” said Dr. Helmut M. Schühsler, managing partner for TVM Capital. “He brings to TVM Capital strategic consulting as well as startup capabilities. His past experience in buyout and growth transactions, strategy development, marketing and sales in our core target market, the pharmaceutical industry, nicely complements our operational expertise and deep scientific and commercial understanding.”

Dr. Parssanedjad completed medical studies at the University of Essen, Germany, at Harvard University, Boston, USA and at St. Johns Medical College, Bangalore, India and holds a doctor degree for his molecular biological work in the field of gene therapy. Prior to joining TVM Capital, he worked as an Engagement Manager for McKinsey & Company, where he served pharmaceutical and private equity clients.

TVM Capital

TVM Capital, founded in 1983, is one of the first venture capital firms formed in Germany and was an early entrant into the US market in 1986. Since inception, TVM Capital has raised more than € 1.3 billion in six fund generations and has established itself as a leading international technology and life science investment group. TVM Capital funds have made investments in more than 235 technology and life science companies including emerging technology sectors such as energy efficiency, renewable energy generation, energy storage and water treatment. Over the life of the firm, TVM Capital has developed specialized, focused teams and dedicated funds to serve high-growth target markets. The TVM Capital investment strategy is to create global businesses that enjoy worldwide access to science, technology, management talent and capital, and to develop them into significant players in their markets. More than 50 TVM Capital backed companies have gone public on European or US stock exchanges. Today, TVM Capital is actively invested in 70 companies.

For more information please visit: www.tvm-capital.com


Publisher Contact Information:

TVM Capital (Formerly Techno Venture Management )
+49 (0) 89 998 992-0
schlesinger@tvm-capital.de

Company profile of TVM Capital (Formerly Techno Venture Management )
Past press releases of TVM Capital (Formerly Techno Venture Management ).

Data


26,229
Tech investments
From our Online Data Service
16,944
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 11N/AInternet services
Oct 11€1.1MKnowledge management
Oct 11N/AInternet services
Oct 11€13.0MBiotechnology
Oct 11N/AMedical devices
Oct 10€50.0MInternet services
Oct 10€23.0MOther Computers & Electronics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.